| Ms Marsha Johnson, | |
|
2410 Rike Dr, Pine Bluff, AR 71603-3935 | |
| (870) 534-2035 | |
| (870) 534-2058 |
| Full Name | Ms Marsha Johnson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2410 Rike Dr, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679585590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR1877 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Marsha Johnson, 2410 Rike Dr, Pine Bluff, AR 71603-3935 Ph: (870) 534-2035 | Ms Marsha Johnson, 2410 Rike Dr, Pine Bluff, AR 71603-3935 Ph: (870) 534-2035 |
News Archive
FzioMed, a medical device company that recently celebrated the 17th anniversary of its founding, has received approval from the Commissioner of the U.S. Food and Drug Administration of its Petition for an independent review of its premarket approval application for Oxiplex Gel.
CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Aragen Bioscience, Inc., a California based contract research and development organization, announced today the signing of a strategic license agreement. This license enables Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient and stable production of preclinical and clinical grade material.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.
A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.
› Verified 3 days ago
Ms. Mari-gray Matthews, OTR.L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3450 W 34th Ave, Pine Bluff, AR 71603 Phone: 870-534-7392 | |
Mr. Belford Kit Nazareno, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Jrmc 1600 West 40th Ave, Pine Bluff, AR 71603 Phone: 870-541-7790 | |
Susan Lanelle Mitchell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2410 Rike Dr, Pine Bluff, AR 71603 Phone: 870-534-2035 Fax: 870-534-2058 | |
Mr. Stacey Bankston, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 Trinity Dr, Pine Bluff, AR 71603 Phone: 870-879-0638 | |
Michael R Olegario, PT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2915 S Hazel St, Pine Bluff, AR 71603 Phone: 870-535-0010 Fax: 870-535-1116 | |
Amy Reece, OTR.L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3450 W 34th Ave, Pine Bluff, AR 71603 Phone: 870-534-7392 Fax: 870-534-7297 | |
Dennis L Morris, PT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2915 S Hazel St, Pine Bluff, AR 71603 Phone: 870-535-0010 Fax: 870-535-0010 |